Impact of anticoagulants in elderly patients who suffer a hip fracture. Should we have a different approach?

Main Article Content

Francisco Lotti
Cristina Maria Elizondo
Jorge Barla
Guido Carabelli
Maria Lilliana Soruco
Bruno Rafael Boietti
Javier Alberto Benchimol


hip fracture; elderly; anticoagulants


Introduction: Hip fracture in the elderly is a frequent problem. Chronic treatment with anticoagulants is common in these patients, and may delay surgery.

Objectives: To compare time to surgery, hospital stay, in-hospital and 90 days complications between anticoagulated (A) and non-anticoagulated (NA) groups.

Methods: Retrospective cohort of >64 years-old patients with acute hip fracture. Period June-2014 to December 2019. We estimated crude and adjusted OR (95%CI) for in-hospital complications with logistic regression model. We report the crude and adjusted HR for readmission and 90-day mortality with Cox proportional hazards model.

Results: Of the 1058 patients, 123 (11%) were anticoagulated. Time to surgery was 26.4 hours (IIQ 13.9-48) in A and 24 hours (IIQ 2.3-48) in NA, p0.001. Hospital stay was 7 days (IIQ 5-9) in A and 6 days (IIQ 5-10.5) NA, p0,000. In-hospital complications were 17 (14%) in A and 81 (9%) in NA, p0.064. The adjusted OR was 1.53 (95%CI 0.8-2.7) p0.138. For 90-day readmission, the crude HR was 1.51 (95%CI 0.99-2.29) p0.053 and the adjusted HR was 1.31 (95%CI 0.85-2.00) p0,09. For 90-day mortality, the crude HR was 0.80 (95%CI 0.45-1.43) p0.464 and the adjusted HR was 0.70 (95% CI 0.39-1.25) p0.239.

Discussion: While we found differences between groups in time to surgery and hospital statistics, their clinical relevance should be reviewed.



Download data is not yet available.


Metrics Loading ...
Abstract 8 | PDF Downloads 5


1. NHDS - National Hospital Discharge Survey Homepage [Internet]. 10 Jan 2018 [cited 10 May 2018]. Available:
2. Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int. 2009;20: 1633–1650.
3. Guo Z, Wills P, Viitanen M, Fastbom J, Winblad B. Cognitive Impairment, Drug Use, and the Risk of Hip Fracture in Persons over 75 Years Old: A Community-based Prospective Study. Am J Epidemiol. 1998;148: 887-892.
4. Makary MA, Segev DL, Pronovost PJ, Syin D, Bandeen-Roche K, Patel P, et al. Frailty as a Predictor of Surgical Outcomes in Older Patients. J Am Coll Surg. 2010;210: 901-908.
5. Wolinsky FD, Fitzgerald JF, Stump TE. The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study. Am J Public Health. 1997;87: 398-403.
6. Eardley WGP, Macleod KE, Freeman H, Tate A. “Tiers of delay”: warfarin, hip fractures, and target-driven care. Geriatr Orthop Surg Rehabil. 2014;5: 103–108.
7. Gleason LJ, Mendelson DA, Kates SL, Friedman SM. Anticoagulation management in individuals with hip fracture. J Am Geriatr Soc. 2014;62: 159-164.
8. Tran T, Delluc A, de Wit C, Petrcich W, Le Gal G, Carrier M. The impact of oral anticoagulation on time to surgery in patients hospitalized with hip fracture. Thromb Res. 2015;136: 962-965.
9. Lawrence JE, Fountain DM, Cundall-Curry DJ, Carrothers AD. Do Patients Taking Warfarin Experience Delays to Theatre, Longer Hospital Stay, and Poorer Survival After Hip Fracture? Clin Orthop Relat Res. 2017;475: 273-279.
10. Bansal R, Watson DK. Surgical delay in acute admissions on warfarin: are we doing enough? Int J Clin Pract. 2005;59: 1283-1288.
11. Ashouri F, Al-Jundi W, Patel A, Mangwani J. Management of warfarin anticoagulation in patients with fractured neck of femur. ISRN Hematol. 2011;2011: 294628.
12. Ranhoff AH, Martinsen MI, Holvik K, Solheim LF. Use of Warfarin is Associated with Delay in Surgery for Hip Fracture in Older Patients. Hosp Pract. 2011;39: 37-40.
13. Bathia N, Malanga G. Ultrasound-guided aspiration and corticosteroid injection in the management of a paralabral ganglion cyst. PM R. 2009;1: 1041-1044.
14. Cohn MR, Levack AE, Trivedi NN, Villa JC, Wellman DS, Lyden JP, et al. The Hip Fracture Patient on Warfarin: Evaluating Blood Loss and Time to Surgery. J Orthop Trauma. 2017;31: 407-413.
15. White RH, Minton SM, Andya MD, Hutchinson R. Temporary reversal of anticoagulation using oral vitamin K. J Thromb Thrombolysis. 2000;10: 149-153.
16. Gidwani S, Davidson N, Trigkilidas D, Blick C, Harborne R, Maurice HD. The Detection of Patients with “Fragility Fractures” in Fracture Clinic – An Audit of Practice with Reference to Recent British Orthopaedic Association Guidelines. Ann R Coll Surg Engl. 2007;89: 147-150.
17. Al-Rashid M, Parker MJ. Anticoagulation management in hip fracture patients on warfarin. Injury. 2005;36: 1311-1315.
18. Kearon C, Hirsh J. Management of Anticoagulation before and after Elective Surgery. N Engl J Med. 1997;336: 1506-1511.
19. Jaffer AK, Brotman DJ, Chukwumerije N. When patients on warfarin need surgery. Cleve Clin J Med. 2003;70: 973-984.
20. Benchimol J, Fiorentini F, Elizondo CM, Boietti BR, Carabelli G, Barla J, et al. Institutional Registry of Elderly Patients With Hip Fracture in a Community-Based Tertiary Care Hospital in Argentina (RIAFC). Geriatr Orthop Surg Rehabil. 2016;7: 121-125.
21. Website [Internet]. [cited 10 May 2018]. Available: (!/home/hospital/seccion/20507)